1 |
SV2C
💬
| [1] ECM-receptor interaction ECM-receptor interaction | Padsevonil
Padsevonil
💬
|
Padsevonil
| [1] 149 149 💬 |
2 |
ITGA4
💬
| [14] PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Focal adhesion, ECM-receptor interaction, Cell adhesion molecules, Hematopoietic cell lineage, Leukocyte transendothelial migration, Intestinal immune network for IgA production, Regulation of actin cytoskeleton, Yersinia infection, Leishmaniasis, Human papillomavirus infection, Hypertrophic cardiomyopathy, Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy | Firategrast
Firategrast
💬
|
Firategrast
| [1] 13 13 💬 |
3 |
ITGA4
💬
| [14] PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Focal adhesion, ECM-receptor interaction, Cell adhesion molecules, Hematopoietic cell lineage, Leukocyte transendothelial migration, Intestinal immune network for IgA production, Regulation of actin cytoskeleton, Yersinia infection, Leishmaniasis, Human papillomavirus infection, Hypertrophic cardiomyopathy, Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy | Natalizumab
Natalizumab
💬
|
Natalizumab
| [6] 13 13, 15, 25, 46, 63, 96 💬 |
4 |
ITGA4
💬
| [14] PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Focal adhesion, ECM-receptor interaction, Cell adhesion molecules, Hematopoietic cell lineage, Leukocyte transendothelial migration, Intestinal immune network for IgA production, Regulation of actin cytoskeleton, Yersinia infection, Leishmaniasis, Human papillomavirus infection, Hypertrophic cardiomyopathy, Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy | Vedolizumab
Vedolizumab
💬
|
Vedolizumab
| [3] 94 94, 96, 97 💬 |
5 |
ITGA4
💬
| [14] PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Focal adhesion, ECM-receptor interaction, Cell adhesion molecules, Hematopoietic cell lineage, Leukocyte transendothelial migration, Intestinal immune network for IgA production, Regulation of actin cytoskeleton, Yersinia infection, Leishmaniasis, Human papillomavirus infection, Hypertrophic cardiomyopathy, Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy | Abrilumab
Abrilumab
💬
|
Abrilumab
| [2] 96 96, 97 💬 |
6 |
ITGB7
💬
| [11] PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Focal adhesion, ECM-receptor interaction, Cell adhesion molecules, Intestinal immune network for IgA production, Regulation of actin cytoskeleton, Human papillomavirus infection, Transcriptional misregulation in cancer, Hypertrophic cardiomyopathy, Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy | Vedolizumab
Vedolizumab
💬
|
Vedolizumab
| [3] 94 94, 96, 97 💬 |
7 |
ITGB7
💬
| [11] PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Focal adhesion, ECM-receptor interaction, Cell adhesion molecules, Intestinal immune network for IgA production, Regulation of actin cytoskeleton, Human papillomavirus infection, Transcriptional misregulation in cancer, Hypertrophic cardiomyopathy, Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy | Etrolizumab
Etrolizumab
💬
|
Etrolizumab
| [2] 96 96, 97 💬 |
8 |
ITGB7
💬
| [11] PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Focal adhesion, ECM-receptor interaction, Cell adhesion molecules, Intestinal immune network for IgA production, Regulation of actin cytoskeleton, Human papillomavirus infection, Transcriptional misregulation in cancer, Hypertrophic cardiomyopathy, Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy | Abrilumab
Abrilumab
💬
|
Abrilumab
| [2] 96 96, 97 💬 |
9 |
VWF
💬
| [8] PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Focal adhesion, ECM-receptor interaction, Complement and coagulation cascades, Platelet activation, Neutrophil extracellular trap formation, Human papillomavirus infection, Coronavirus disease - COVID-19 | Caplacizumab
Caplacizumab
💬
|
Caplacizumab
| [1] 64 64 💬 |
10 |
SV2B
💬
| [1] ECM-receptor interaction ECM-receptor interaction | Padsevonil
Padsevonil
💬
|
Padsevonil
| [1] 149 149 💬 |
11 |
SV2A
💬
| [1] ECM-receptor interaction ECM-receptor interaction | Levetiracetam
Levetiracetam
💬
|
Levetiracetam
| [5] 2 2, 4, 6, 13, 307 💬 |
12 |
SV2A
💬
| [1] ECM-receptor interaction ECM-receptor interaction | Brivaracetam
Brivaracetam
💬
|
Brivaracetam
| [2] 149 149, 309 💬 |
13 |
SV2A
💬
| [1] ECM-receptor interaction ECM-receptor interaction | Padsevonil
Padsevonil
💬
|
Padsevonil
| [1] 149 149 💬 |